Patents by Inventor Einat Galamidi-Cohen

Einat Galamidi-Cohen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SELECTION AND USE OF UMBILICAL CORD CELL FRACTIONS SUITABLE FOR TRANSPLANTATION
    Publication number: 20230340410
    Abstract: Methods of selecting umbilical cord blood units for ex-vivo expansion, separation of CD133+/CD34+ positive and uncultured CD133+/CD34+ negative fractions, methods for expanding the selected CD133+/CD34+ fraction, selection of expanded populations of CD133+/CD34+ cord blood cells for transplantation to subjects in need thereof and the therapeutic use of suitable selected, ex-vivo expanded CD133+/CD34+ and unselected CD133/CD34 negative cord blood fractions for transplantation in the clinical setting, for treatment of hematological malignancies are provided. The present invention also envisions kits comprising the expanded and unselected cord blood fractions.
    Type: Application
    Filed: June 28, 2023
    Publication date: October 26, 2023
    Inventors: Tony PELED, Einat Galamidi Cohen, David Synder
  • Selection and use of umbilical cord cell fractions suitable for transplantation
    Patent number: 11746325
    Abstract: Methods of selecting umbilical cord blood units for ex-vivo expansion, separation of CD133+/CD34+ positive and uncultured CD133+/CD34+ negative fractions, methods for expanding the selected CD133+/CD34+ fraction, selection of expanded populations of CD133+/CD34+ cord blood cells for transplantation to subjects in need thereof and the therapeutic use of suitable selected, ex-vivo expanded CD133+/CD34+ and unselected CD133/CD34 negative cord blood fractions for transplantation in the clinical setting, for treatment of hematological malignancies are provided. The present invention also envisions kits comprising the expanded and unselected cord blood fractions.
    Type: Grant
    Filed: May 16, 2017
    Date of Patent: September 5, 2023
    Assignee: Gamida Cell Ltd.
    Inventors: Tony Peled, Einat Galamidi Cohen, David Snyder
  • SELECTION AND USE OF UMBILICAL CORD CELL FRACTIONS SUITABLE FOR TRANSPLANTATION
    Publication number: 20200172863
    Abstract: Methods of selecting umbilical cord blood units for ex-vivo expansion, separation of CD133+/CD34+ positive and uncultured CD133+/CD34+ negative fractions, methods for expanding the selected CD133+/CD34+ fraction, selection of expanded populations of CD133+/CD34+ cord blood cells for transplantation to subjects in need thereof and the therapeutic use of suitable selected, ex-vivo expanded CD133+/CD34+ and unselected CD133/CD34 negative cord blood fractions for transplantation in the clinical setting, for treatment of hematological malignancies are provided. The present invention also envisions kits comprising the expanded and unselected cord blood fractions.
    Type: Application
    Filed: May 16, 2017
    Publication date: June 4, 2020
    Applicant: Gamida Cell Ltd.
    Inventors: Tony PELED, Einat Galamidi COHEN, David SNYDER
  • Compositions capable of facilitation penetration across a biological barrier
    Publication number: 20070172517
    Abstract: This invention relates to novel pharmaceutical compositions capable of facilitating penetration of at least one effector across biological barriers. The invention also relates to methods of treating or preventing diseases by administering these compositions to affected subjects.
    Type: Application
    Filed: September 17, 2004
    Publication date: July 26, 2007
    Inventors: Shmuel Ben-Sasson, Einat Galamidi-Cohen